Search
for
Sort by
Research 211–240 of 1000+
- Fibroblast state switching orchestrates dermal maturation and wound healing
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- 8 / Experimental induction of tenuazonic acid toxicity in mice model
- The therapeutic use of topical contact sensitizers in benign dermatoses
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- The therapeutic use of topical contact sensitizers in benign dermatoses
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors
- Covid induced telogen effluvium (CITE): An insight
- The COVID-19 pandemic and its skin effects
- Diseases of Honeybee (Apis mellifera)
- Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome
- Successful treatment of three cases of pediatric alopecia areata using a combination of corticosteroids, minoxidil, immunomodulator and light-emitting diode therapy
- Madarosis and facial keratinaceous spines
- A small multigene hydroxyproline-O-galactosyltransferase family functions in arabinogalactan-protein glycosylation, growth and development in Arabidopsis
- Defining trichoscopy clue in children with alopecia areata
- Pathological sequelae of long-haul COVID
- Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
- Trichodysplasia spinulosa: a polyomavirus infection specifically targeting follicular keratinocytes in immunocompromised patients
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- A Reappraisal of the Antiviral Properties of and Immune Regulation through Dietary Phytochemicals
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Natural Products as A Promising Therapy for SARS COV-2; An Overview
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>